Venture
Intrinsic Therapeutics Inc
Latest Form D 2023-12-08- CIK 1213628
- State MA
- Other Health Care
- 9 Form D offerings since 2010-02-25
- Total sold
- $219M
- across 9 offerings
- Rounds
- 9
- Form D offerings since 2010-02-25
- Latest round
- $55.5M
- 2023-12-08 · 021-499150
- Investors
- 9
- on the latest round
Connected
named in its Form D filingsOfferings · since 2010-02-259 Form D offeringsExemptions506(b) · 506People · Item 3Cary Hagan + 5 moreInvestors · dashboard3 inferred investors
Intrinsic Therapeutics IncCIK 1213628
Round timeline
amount sold · by first filed2023-12-08 · $55.5M
- 2010-02-25$18M021-51600
- 2012-11-08$11.7M021-186686
- 2014-09-17$17.3M021-224858
- 2016-12-16$28.4M021-276448
- 2019-04-23$38.8M021-337885
- 2021-04-07$38.4M021-394982
- 2023-04-13$5.9M021-478810
- 2023-08-18$5.5M021-490159
- 2023-12-08$55.5M021-499150
Hover a dot or row, or tab through the dots · bars scaled to the largest round ($55.5M)
Form D offerings
One line per offering, amendments folded in, newest first
| File | First filed | Latest | Sought | Sold | Investors | Exemptions |
|---|---|---|---|---|---|---|
| 021-499150 | First filed2023-12-08 | Latest2023-12-08 | Sought$68.5M | Sold$55.5M | Investors9 | Exemptions506(b) |
| 021-490159 | First filed2023-08-18 | Latest2023-08-18 | Sought$5.5M | Sold$5.5M | Investors18 | Exemptions506(b) |
| 021-478810 | First filed2023-04-13 | Latest2023-04-13 | Sought$7.5M | Sold$5.9M | Investors9 | Exemptions506(b) |
| 021-394982 | First filed2021-04-07 | Latest2021-04-07 | Sought$40M | Sold$38.4M | Investors13 | Exemptions506(b) |
| 021-337885 | First filed2019-04-23 | Latest2019-04-23 | Sought$41.7M | Sold$38.8M | Investors28 | Exemptions506(b) |
| 021-276448 | First filed2016-12-16 | Latest2017-03-21 | Sought$28.4M | Sold$28.4M | Investors22 | Exemptions506(b) |
| 021-224858 | First filed2014-09-17 | Latest2014-09-17 | Sought$20.9M | Sold$17.3M | Investors28 | Exemptions506(b) |
| 021-186686 | First filed2012-11-08 | Latest2012-11-08 | Sought$12.3M | Sold$11.7M | Investors11 | Exemptions506 |
| 021-51600 | First filed2010-02-25 | Latest2010-02-25 | Sought$20M | Sold$18M | Investors11 | Exemptions506 |
Who backs Intrinsic Therapeutics Inc — 3 inferred investors — and every Form D as filedSee plans
People
Named in Item 3 of its latest Form D, filed 2023-12-08
| Name | Relationship |
|---|---|
| Cary Hagan | RelationshipExecutive Officer, Director |
| Gregory H. Lambrecht | RelationshipDirector |
| Ryan Drant | RelationshipDirector |
| Jeani Deagardellel | RelationshipDirector |
| Brian Verrier | RelationshipDirector |
| Peter Pizzo | RelationshipExecutive Officer |
Facts
As its latest Form D states them
- Industry
- Other Health Care
- State
- Massachusetts (MA)
- Exemptions
- Rule 506(b); Rule 506
- First filed
- 2010-02-25
- Latest filing
- 2023-12-08
Who backs Intrinsic Therapeutics Inc
Form D names a startup's officers and directors, not its investors. The dashboard infers them — the venture funds whose own filings and people overlap this company's rounds — and lays every Form D and amendment it filed beside the totals above.
- Inferred investors — the funds and firms behind it, from co-filings and shared people
- Every Form D and amendment as filed, with what each one stated
- Its rounds in sequence: the gap between them and whether they grew
- Everyone its filings name, linked to their other companies, with its addresses and phone numbers
Part of the Venture plan — $140/mo at launch pricing ($350 list)
See plansExternal link: SEC Filings ↗